This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Brand Names
- Bexsero
- Generic Name
- Neisseria meningitidis serogroup b fhbp fusion protein antigen
- DrugBank Accession Number
- DB10784
- Background
Not Available
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Other vaccines - Synonyms
- Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Bexsero Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 mcg/0.5ml) + Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 mcg/0.5ml) + Neisseria meningitidis serogroup b nada protein antigen (50 mcg/0.5ml) + Neisseria meningitidis serogroup b nhba fusion protein antigen (50 mcg/0.5ml) Injection, suspension Intramuscular Glaxo Smith Kline Vaccines S.R.L. 2021-02-08 Not applicable EU 
Bexsero Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 ug/0.5mL) + Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 ug/0.5mL) + Neisseria meningitidis serogroup b nada protein antigen (50 ug/0.5mL) + Neisseria meningitidis serogroup b nhba fusion protein antigen (50 ug/0.5mL) Injection, suspension Intramuscular GlaxoSmithKline Biologicals SA 2016-12-01 Not applicable US 
Bexsero Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 mcg/0.5ml) + Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 mcg/0.5ml) + Neisseria meningitidis serogroup b nada protein antigen (50 mcg/0.5ml) + Neisseria meningitidis serogroup b nhba fusion protein antigen (50 mcg/0.5ml) Injection, suspension Intramuscular Glaxo Smith Kline Vaccines S.R.L. 2021-03-01 Not applicable EU BEXSERO Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 mcg) + Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 mcg) + Neisseria meningitidis serogroup b nada protein antigen (50 mcg) + Neisseria meningitidis serogroup b nhba fusion protein antigen (50 mcg) Injection, suspension Intramuscular Glaxosmithkline Vaccines S.R.L. 2014-07-08 Not applicable Italy 
Bexsero Neisseria meningitidis serogroup b fhbp fusion protein antigen (50 mcg/0.5ml) + Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle (25 mcg/0.5ml) + Neisseria meningitidis serogroup b nada protein antigen (50 mcg/0.5ml) + Neisseria meningitidis serogroup b nhba fusion protein antigen (50 mcg/0.5ml) Injection, suspension Intramuscular Glaxo Smith Kline Vaccines S.R.L. 2021-02-08 Not applicable EU
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 25DB599G64
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data4 Completed Basic Science Meningitis 1 somestatus stop reason just information to hide 4 Completed Health Services Research Healthy Volunteers (HV) 1 somestatus stop reason just information to hide 4 Completed Other Meningococcal Meningitis 1 somestatus stop reason just information to hide 4 Completed Other Meningococcal Serogroup B 1 somestatus stop reason just information to hide 4 Completed Prevention Infants, Premature / Meningococcal Disease / Vaccinations 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, suspension Intramuscular Suspension Intramuscular Injection, solution Intramuscular - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53